0
Skip to Content
Celea Therapeutics
Deupirfenidone
Patients & Physicians
About Us
Careers
News
Contact Us
Celea Therapeutics
Deupirfenidone
Patients & Physicians
About Us
Careers
News
Contact Us
Deupirfenidone
Patients & Physicians
About Us
Careers
News
Contact Us
Jamison Wright 10/29/26 Jamison Wright 10/29/26

Sven Dethlefs, PhD

Chief Executive Officer

Read More
Jamison Wright 10/29/26 Jamison Wright 10/29/26

Vishwas (Vish) Setia, MBA

Chief Financial Officer

Read More
Jamison Wright 10/29/26 Jamison Wright 10/29/26

Paul Audhya, MD, MBA

Chief Medical Officer

Read More
Jamison Wright 10/29/26 Jamison Wright 10/29/26

Ronen Tamir, BSc, MBA

Chief Operating Officer

Read More
Jamison Wright 10/29/26 Jamison Wright 10/29/26

David M, Stark, JD

General Counsel and Chief Compliance Officer

Read More

Celea Therapeutics

6 Tide Street, Suite 400
Boston, MA 02210


info@celeatx.com

DEUPIRFENIDONE
PATIENTS & PHYSICIANS
ABOUT US
CAREERS
NEWS & PUBLICATIONS
CONTACT

© 2026 Celea Therapeutics, Inc. All rights reserved. Expanded Access Policy

The FDA and corresponding regulatory authorities will ultimately review our clinical results and determine whether deupirfenidone is safe and effective. No regulatory agency has made any such determination that deupirfenidone is safe or effective for use by the general public for any indication.